Is Migraine a Progressive Brain Disease?

JAMA

Volumn 291, Issue 4, 2004, Pages 493-494

  Lipton, Richard B ^a   Pan, Jullie ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DYSFUNCTION; BRAIN INFARCTION; CEREBELLUM; CHRONIC DISEASE; EDITORIAL; HEADACHE; HUMAN; MIGRAINE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIAQUEDUCTAL GRAY MATTER; PREVALENCE; PRIORITY JOURNAL; STROKE; WHITE MATTER;

EID: 1642540448     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.4.493     Document Type: Editorial

References (17)

1. Kruit MC, van Buchem MA, Hofman PAM, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291:427-434.
2. Fazekas F, Koch M, Schmidt R, et al. The prevalence of cerebral damage varies with migraine type: a MRI study. Headache. 1992;32:287-291.
3. Pavese N, Canapicchi R, Nuti A, et al. White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia. 1994;14:342-345.
4. De Benedittis G, Lorenzetti A, Sina C, et al. Magnetic resonance imaging in migraine and tension-type headache. Headache. 1995;35:264-268.
5. Milhaud D, Bogousslavsky J, Van Melle G, et al. Ischemic stroke and active migraine. Neurology. 2001;57:1805-1811.
6. Hoekstra-van Dalen RA, Cillessen JP, Kappelle LJ, et al. Cerebral infarcts associated with migraine: clinical features, risk factors and follow-up. J Neurol. 1996;243:511-515.
7. Ducros A, Denier C, Joutel A, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med. 2001;345:17-24.
8. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87:543-552.
9. Sandor PS, Mascia A, Seidel L, et al. Subclinical cerebellar impairment in the common types of migraine: a three-dimensional analysis of reaching movements. Ann Neurol. 2001;49:668-672.
10. Donaghy M, Chang CL, Poulter N. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry. 2002;73:747-750.
11. Welch KMA, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache. 2001;41:629-637.
12. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003;106(1-2):81-89.
13. Scher AI, Lipton RB, Stewart W. Risk factors for chronic daily headache. Curr Pain Headache Rep. 2002;6:486-491.
14. Yarnitsky D, Goor-Aryeh I, Bajwa ZH, et al. 2003 Wolff Award: possible parasympathetic contributions to peripheral and central sensitization during migraine. Headache. 2003;43:704-714.
15. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000;123:1703-1709.
16. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:754-763.
17. Loder E, Biondi D. Disease modification in migraine: a concept that has come of age? Headache. 2003;43:135-143.